Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:1195768-06-9,CAS 1195768-06-9,CAS NO 1195768-06-9
Conbott Pharmtech Co.,Ltd. 1195768-06-9,CAS 1195768-06-9,CAS NO 1195768-06-9
Home > Products > Inhibitors > BRAF Inhibitors > High Purity of GSK-2118436 Dabrafenib Mesylate 1195768-06-9
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit
High Purity of GSK-2118436 Dabrafenib Mesylate 1195768-06-9

High Purity of GSK-2118436 Dabrafenib Mesylate 1195768-06-9

Share to:  
    Payment Type: T/T,L/C
    Min. Order: 1 Gram
    Delivery Time: 7 Days

Basic Info

Model No.: 1195768-06-9

Additional Info

Packaging: As quantity

Productivity: As requiry

Brand: CONBOTTPHARM

Transportation: Air

Place of Origin: CHINA

Supply Ability: Commercial

Certificate: DOCUMENT SUPPORT

Product Description

Competitive High Purity of GSK-2118436 Dabrafenib Mesylate Inhibitor


Dabrafenib is a kinase inhibitor with anticancer activity. we can make good purity (99% single impurity< 0.1%) we have rich experience in making dabrafenib mesylate Cas 1195768-06-9 Dabrafenib Mesylate manufacturers and suppliers in China.

Thera. Category: Anti- cancer

Cas No.: 1195768-06-9

Synonym: Dabrafenib Mesylate(GSK-2118436B);Dabrafenib Mesylate;GSK 2118436 Mesylate;GSK 2118436B;GSK2118436 Mesylate;GSK-2118436 Mesylate;Dabrafenib Mesylate (API);GSK 2118436 methanesulfonate salt

Molecular Formula:C24H24F3N5O5S3

1195768-06-9 Dabrafenib

Molecular Weight: 615.6680696

Assay: ≥97.%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage: Dabrafenib, also known as GSK2118436, is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. On May 29, 2013, FDA approved this drug.

Related Intermediates :
1. CAS 630-22-8,2,2,2-Trimethylthioacetamide
2. CAS 914223-43-1,3-AMINO-2-FLUOROBENZOIC ACID

Looking for ideal 1195768-06-9 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the CAS 1195768-06-9 are quality guaranteed. We are China Origin Factory of CAS NO 1195768-06-9. If you have any question, please feel free to contact us.

Product Categories : Inhibitors > BRAF Inhibitors

Product Images
  • High Purity of GSK-2118436 Dabrafenib Mesylate 1195768-06-9
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2019 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?